Drug Shortage Report for APO-VALSARTAN/HCTZ
| Report ID | 263 |
| Drug Identification Number | 02382555 |
| Brand name | APO-VALSARTAN/HCTZ |
| Common or Proper name | VALSARTAN/HCTZ |
| Company Name | APOTEX INC |
| Market Status | DORMANT |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE VALSARTAN |
| Strength(s) | 12.5MG 160MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 BTL & 30 BLS |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2016-01-04 |
| Estimated end date | |
| Actual end date | 2018-12-28 |
| Shortage status | Resolved |
| Updated date | 2019-03-21 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.